CURR: CURRENC Group Inc. Stock

by  •  • Comments Off on CURR: CURRENC Group Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 56.76
Enterprise Value ($M) 39.33
Book Value ($M) -41.76
Book Value / Share -0.90
Price / Book -1.36
NCAV ($M) -58.95
NCAV / Share -1.27
Price / NCAV -0.96

Profitability (mra)
Return on Invested Capital (ROIC) n/a
Return on Assets (ROA) -0.31
Return on Equity (ROE) n/a

Liquidity (mrq)
Quick Ratio 0.61
Current Ratio 0.61

Balance Sheet (mrq) ($M)
Current Assets 91.28
Assets 108.47
Liabilities 150.23
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 46.44
Operating Income -27.38
Net Income -39.48
Earnings Per Share Basic And Diluted n/a
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 3.45
Cash from Investing -0.57
Cash from Financing 2.02

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-14 13G/A Polar Asset Management Partners Inc. 0.00 -100.00
11-14 13G/A Glazer Capital, Llc 0.00 -100.00
11-13 13G/A Cowen And Company, Llc 0.00 -100.00
09-10 13G/A Vivaldi Asset Management, LLC 0.00 -100.00
09-05 13G/A Wolverine Asset Management Llc 0.00 -100.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q
2024-10-09 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-10-09 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)
2024-10-09 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-05-08 29,251 94,879 30.83
2025-05-07 6,376 36,035 17.69
2025-05-06 36,282 130,633 27.77
2025-05-05 49,167 127,441 38.58

(click for more detail)

Similar Companies
CRON – Cronos Group Inc. CRSP – CRISPR Therapeutics AG
CRVS – Corvus Pharmaceuticals, Inc. CVAC – CureVac N.V.
EOLS – Evolus, Inc.


Financial data and stock pages provided by
Fintel.io